EN HU

Rebenku István

Rebenku István

Publication list

2024
1.
Nagy, L., Mezősi-Csaplár, M., Rebenku, I., Vereb, G., Szöőr, Á.: Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.
Journal metrics:
Q1 Immunology (2023)
Q1 Immunology and Allergy (2023)
2023
2.
Takács, L., Kemenes, G., Bajdik, B., Fodor, M., Rebenku, I., Vereb, G.: Examination of limbal stromal structures by in vivo confocal microscopy and anterior segment optical coherence tomography angiography: correlation with immunohistological analysis of limbal niche structures.
Invest. Ophthalmol. Vis. Sci. 64 (8), 4026, 2023.
3.
Rebenku, I., Lloyd, C. B., Szöllősi, J., Vereb, G.: Pixel-by-pixel autofluorescence corrected FRET in fluorescence microscopy improves accuracy for samples with spatially varied autofluorescence to signal ratio.
Sci. Rep. 13 (1), 1-15, (article identifier: 2934), 2023.
Journal metrics:
D1 Multidisciplinary
4.
Rebenku, I., Bartha, F., Katona, T., Zsebik, B., Antalffy, G., Takács, L., Molnár, B., Vereb, G.: Taking molecular pathology to the next level: whole slide multicolor confocal imaging with the Pannoramic Confocal digital pathology scanner.
Cytom. Part A. 103 (3), 198-207, 2023.
Journal metrics:
Q2 Cell Biology
Q1 Histology
Q1 Pathology and Forensic Medicine
2021
5.
Bankó, C., Nagy, Z. L., Nagy, M., Szemán-Nagy, G., Rebenku, I., Imre, L., Tiba, A., Hajdu, A., Szöllősi, J., Kéki, S., Bacsó, Z.: Isocyanide Substitution in Acridine Orange Shifts DNA Damage-Mediated Phototoxicity to Permeabilization of the Lysosomal Membrane in Cancer Cells.
Cancers (Basel). 13 (22), 1-24, 2021.
Journal metrics:
Q2 Cancer Research
Q1 Oncology
6.
Csomós, I., Nagy, P., Filep, C. B., Rebenku, I., Nizsalóczki, E., Kovács, T., Vámosi, G., Mátyus, L., Dóczy-Bodnár, A.: Opposing Effects of Chelidonine on Tyrosine and Serine Phosphorylation of STAT3 in Human Uveal Melanoma Cells.
Int. J. Mol. Sci. 22 (23), 1-14, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2020
7.
Nemes, D., Kovács, R. L., Nagy, F., Tóth, Z., Herczegh, P., Borbás, A., Kelemen, V., Pfliegler, V. P., Rebenku, I., Hajdu, P., Fehér, P., Ujhelyi, Z., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.
Eur. J. Pharm. Sci. 143, 1-9, 2020.
Journal metrics:
Q1 Pharmaceutical Science
8.
Hajdu, T., Váradi, T., Rebenku, I., Kovács, T., Szöllősi, J., Nagy, P.: Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains.
Front. Cell. Dev. Biol. 8, 1-53, 2020.
Journal metrics:
Q1 Developmental Biology
Q1 Cell Biology
2019
9.
Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., Kovács, R. L.: Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.
Journal metrics:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
DEENK University of Debrecen
© 2012 University of Debrecen